FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely dentistry, and may be used for treating hyperesthesia of intact primary and secondary teeth in case of caries and non-caries lesions, dental hard tissue abrasion, reduced dental sensation caused by whitening, as well as tooth preparation, and periodontal manifestations. A dental formulation for treating dental hyperesthesia contains L-arginine, hydroxyapatite of crystal size 30-40 nm*100-200 nm in the form of 10.0-20% aqueous paste, cetrimide as an antiseptic preparation, monoatomic alcohol and water in the following proportions (wt %): hydroxyapatite - 1.0-15.0; L-arginine - 1.0-10.0; cetrimide - 0.1-1.0; monoatomic alcohol - 10.0-20.0; distilled water - to 100.
EFFECT: formulation combines the properties of desentitiser and remineraliser represents a suspension resistant to prolonged storage and applicable both in clinics, and domiciliary.
3 tbl, 2 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
HYDROGEL FOR REMINERALISATION OF HARD DENTAL TISSUES | 2019 |
|
RU2691960C1 |
MEANS FOR TEETH HARD TISSUE REMINERALIZATION | 2016 |
|
RU2627624C1 |
METHOD OF TREATING DENTINAL HYPERSENSITIVITY | 2013 |
|
RU2539392C1 |
METHOD OF TREATMENT AND PREVENTION OF HYPERESTHESIA OF DENTAL TISSUE | 2017 |
|
RU2673150C1 |
METHOD OF TREATING DENTAL HYPERESTHESIA | 2010 |
|
RU2419437C1 |
DENTAL GEL FOR REMINERALIZATION OF HARD TISSUES OF TEETH AND METHOD OF REMINERALIZATION OF HARD TISSUES OF TEETH | 2017 |
|
RU2677231C1 |
METHOD FOR TREATMENT OF TEETH HYPERESTHESIA IN PATIENTS ON BACKGROUND OF SOMATIC DISEASES | 2017 |
|
RU2638293C1 |
DENTAL DISEASE AND PARODONTIUM PROPHYLAXIS COMPOSITION | 2002 |
|
RU2204990C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING DENTAL AND PERIODONTIC DISEASES | 2001 |
|
RU2188626C1 |
ORAL CAVITY DISEASE PROPHYLAXIS COMPOUND | 2002 |
|
RU2204991C1 |
Authors
Dates
2012-11-27—Published
2011-10-31—Filed